FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1732-1736 December 28, 1995 Number 26 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Pregnant women with bacterial vaginosis may be at increased risk for preterm delivery. We investigated whether treatment with metronidazole and erythromycin during the second trimester would lower the incidence of delivery before 37 weeks' gestation.

Methods In 624 pregnant women at risk for delivering prematurely, vaginal and cervical cultures and other laboratory tests for bacterial vaginosis were performed at a mean of 22.9 weeks' gestation. We then performed a 2:1 double-blind randomization to treatment with metronidazole and erythromycin (433 women) or placebo (191 women). After treatment, the vaginal and cervical tests were repeated and a second course of treatment was given to women who had bacterial vaginosis at that time (a mean of 27.6 weeks' gestation).

Results A total of 178 women (29 percent) delivered infants at less than 37 weeks' gestation. Eight women were lost to follow-up. In the remaining population, 110 of the 426 women assigned to metronidazole and erythromycin (26 percent) delivered prematurely, as compared with 68 of the 190 assigned to placebo (36 percent, P = 0.01). However, the association between the study treatment and lower rates of prematurity was observed only among the 258 women who had bacterial vaginosis (rate of preterm delivery, 31 percent with treatment vs. 49 percent with placebo; P = 0.006). Of the 358 women who did not have bacterial vaginosis when initially examined, 22 percent of those assigned to metronidazole and erythromycin and 25 percent of those assigned to placebo delivered prematurely (P = 0.55). The lower rate of preterm delivery among the women with bacterial vaginosis who were assigned to the study treatment was observed both in women at risk because of previous preterm delivery (preterm delivery in the treatment group, 39 percent; and in the placebo group, 57 percent; P = 0.02) and in women who weighed less than 50 kg before pregnancy (preterm delivery in the treatment group, 14 percent; and in the placebo group, 33 percent; P = 0.04).

Conclusions Treatment with metronidazole and erythromycin reduced rates of premature delivery in women with bacterial vaginosis and an increased risk for preterm delivery.

Source Information

From the Division of Maternal–Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 S. 20th St., Birmingham, AL 35233-7333, where reprint requests should be addressed to Dr. Hauth.

Full Text of this Article

This article has been cited by other articles:

• U.S. Preventive Services Task Force, (2008). Screening for Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: U.S. Preventive Services Task Force Recommendation Statement. ANN INTERN MED 148: 214-219 [Abstract] [Full Text]  
• Nygren, P., Fu, R., Freeman, M., Bougatsos, C., Klebanoff, M., Guise, J.-M. (2008). Evidence on the Benefits and Harms of Screening and Treating Pregnant Women Who Are Asymptomatic for Bacterial Vaginosis: An Update Review for the U.S. Preventive Services Task Force. ANN INTERN MED 148: 220-233 [Abstract] [Full Text]  
• Simhan, H. N., Caritis, S. N. (2007). Prevention of Preterm Delivery. NEJM 357: 477-487 [Full Text]  
• Chatterjee, J., Gullam, J., Vatish, M., Thornton, S. (2007). The management of preterm labour. Arch. Dis. Child. Fetal Neonatal Ed. 92: F88-F93 [Full Text]  
• Keane, F, Ison, C A, Noble, H, Estcourt, C (2006). Bacterial vaginosis. Sex. Transm. Infect. 82: iv16-iv18 [Full Text]  
• Eckert, L. O. (2006). Acute Vulvovaginitis. NEJM 355: 1244-1252 [Full Text]  
• Simhan, H. N., Bodnar, L. M. (2006). Prepregnancy Body Mass Index, Vaginal Inflammation, and the Racial Disparity in Preterm Birth. Am J Epidemiol 163: 459-466 [Abstract] [Full Text]  
• Mullick, S, Watson-Jones, D, Beksinska, M, Mabey, D (2005). Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex. Transm. Infect. 81: 294-302 [Abstract] [Full Text]  
• Bhutta, Z. A., Darmstadt, G. L., Hasan, B. S., Haws, R. A. (2005). Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence. Pediatrics 115: 519-617 [Abstract] [Full Text]  
• Haas, J. S., Fuentes-Afflick, E., Stewart, A. L., Jackson, R. A., Dean, M. L., Brawarsky, P., Escobar, G. J. (2005). Prepregnancy Health Status and the Risk of Preterm Delivery. Arch Pediatr Adolesc Med 159: 58-63 [Abstract] [Full Text]  
• Wilks, M., Wiggins, R., Whiley, A., Hennessy, E., Warwick, S., Porter, H., Corfield, A., Millar, M. (2004). Identification and H2O2 Production of Vaginal Lactobacilli from Pregnant Women at High Risk of Preterm Birth and Relation with Outcome. J. Clin. Microbiol. 42: 713-717 [Abstract] [Full Text]  
• Atkins, D. (2003). First new screening recommendations from the third US Preventive Services Task Force. BMJ 327: E21-24 [Full Text]  
• Greene, M. F. (2003). Progesterone and Preterm Delivery -- Deja Vu All Over Again. NEJM 348: 2453-2455 [Full Text]  
• Onderdonk, A. B., Lee, M.-L., Lieberman, E., Delaney, M. L., Tuomala, R. E. (2003). Quantitative Microbiologic Models for Preterm Delivery. J. Clin. Microbiol. 41: 1073-1079 [Abstract] [Full Text]  
• Nelson, D. B., Macones, G. (2002). Bacterial Vaginosis in Pregnancy: Current Findings and Future Directions. Epidemiol Rev 24: 102-108 [Full Text]  
• Martino, J. L., Vermund, S. H. (2002). Vaginal Douching: Evidence for Risks or Benefits to Women's Health. Epidemiol Rev 24: 109-124 [Full Text]  
• BIRLEY, H., DUERDEN, B.I., HART, C.A. (2002). Sexually transmitted diseases: microbiology and management Proceedings of the Seventh Liverpool Tropical School Bayer Symposium on Microbial Disease held on 6 February 2000. J Med Microbiol 51: 793-807 [Full Text]  
• Workowski, K. A., Levine, W. C., Wasserheit, J. N. (2002). U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: An Opportunity To Unify Clinical and Public Health Practice. ANN INTERN MED 137: 255-262 [Abstract] [Full Text]  
• Davenport, E.S., Williams, C.E.C.S., Sterne, J.A.C., Murad, S., Sivapathasundram, V., Curtis, M.A. 5 (2002). Maternal Periodontal Disease and Preterm Low Birthweight: Case-Control Study. JDR 81: 313-318 [Abstract] [Full Text]  
• Guinn, D., Gibbs, R. (2002). Infection-related Preterm Birth: A Review of the Evidence. NeoReviews 3: e86-96 [Full Text]  
• Holzman, C., Leventhal, J. M., Qiu, H., Jones, N. M., Wang, J. (2001). Factors Linked to Bacterial Vaginosis in Nonpregnant Women. Am. J. Public Health 91: 1664-1670 [Abstract] [Full Text]  
• Klebanoff, M. A., Carey, J. C., Hauth, J. C., Hillier, S. L., Nugent, R. P., Thom, E. A., Ernest, J.M., Heine, R. P., Wapner, R. J., Trout, W., Moawad, A., Miodovnik, M., Sibai, B. M., Dorsten, J. P. V., Dombrowski, M. P., O'Sullivan, M. J., Varner, M., Langer, O., McNellis, D., Roberts, J. M., Leveno, K. J., the National Institute of Child Health Human Devel, (2001). Failure of Metronidazole to Prevent Preterm Delivery among Pregnant Women with Asymptomatic Trichomonas vaginalis Infection. NEJM 345: 487-493 [Abstract] [Full Text]  
• Goldenberg, R. L., Jobe, A. H. (2001). Prospects for Research in Reproductive Health and Birth Outcomes. JAMA 285: 633-639 [Abstract] [Full Text]  
• Vishwanath, S., Talwar, V., Prasad, R., Coyaji, K., Elias, C. J, de Zoysa, I. (2000). Syndromic management of vaginal discharge among women in a reproductive health clinic in India. Sex. Transm. Infect. 76: 303-306 [Abstract] [Full Text]  
• Peipert, J. F. (2000). Ambulatory Gynecology. JAMA 283: 2630-2632 [Full Text]  
• Goldenberg, R. L., Hauth, J. C., Andrews, W. W. (2000). Intrauterine Infection and Preterm Delivery. NEJM 342: 1500-1507 [Full Text]  
• Hall, R. T. (2000). Prevention of Premature Birth: Do Pediatricians Have a Role?. Pediatrics 105: 1137-1140 [Abstract] [Full Text]  
• Carey, J. C., Klebanoff, M. A., Hauth, J. C., Hillier, S. L., Thom, E. A., Ernest, J.M., Heine, R. P., Nugent, R. P., Fischer, M. L., Leveno, K. J., Wapner, R., Varner, M., Trout, W., Moawad, A., Sibai, B. M., Miodovnik, M., Dombrowski, M., O'Sullivan, M. J., VanDorsten, J. P., Langer, O., Roberts, J., The National Institute of Child Health Human Devel, (2000). Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis. NEJM 342: 534-540 [Abstract] [Full Text]  
• Sauitz, D. A, Gissler, M., Jarvelin, M.-R., Louhiala, P., Rahkonen, O., Hemminki, E. (2000). Can children's health be predicted by perinatal health?. Int J Epidemiol 29: 189-190 [Full Text]  
• Cnattingius, S., Granath, F., Petersson, G., Harlow, B. L. (1999). The Influence of Gestational Age and Smoking Habits on the Risk of Subsequent Preterm Deliveries. NEJM 341: 943-948 [Abstract] [Full Text]  
• Merchant, J. S., Oh, M. K., Klerman, L. V. (1999). Douching: A Problem for Adolescent Girls and Young Women. Arch Pediatr Adolesc Med 153: 834-837 [Abstract] [Full Text]  
• Brocklehurst, P. (1999). Infection and preterm delivery. BMJ 318: 548-549 [Full Text]  
• Kogan, M. D., Martin, J. A., Ventura, S. J., Alexander, G. R., Kotelchuck, M., Frigoletto, F. D., Rosenberg, K. D., Rooks, J. P., Misra, D. P., Guyer, B., Kogan, M. D., Martin, J. A., Ventura, S. J., Alexander, G. R., Kotelchuck, M., Frigoletto, F. D. (1998). Benefits and Limitations of Prenatal Care. JAMA 280: 2071-2073 [Full Text]  
• Wilson-Costello, D., Borawski, E., Friedman, H., Redline, R., Fanaroff, A. A., Hack, M. (1998). Perinatal Correlates of Cerebral Palsy and Other Neurologic Impairment Among Very Low Birth Weight Children. Pediatrics 102: 315-322 [Abstract] [Full Text]  
• Goldenberg, R. L., Rouse, D. J. (1998). Prevention of Premature Birth. NEJM 339: 313-320 [Full Text]  
• Muli, F., Struthers, J. K. (1998). Use of a Continuous-Culture Biofilm System To Study the Antimicrobial Susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. Antimicrob. Agents Chemother. 42: 1428-1432 [Abstract] [Full Text]  
• (1998). Management of bacterial vaginosis. DTB 36: 33-35 [Abstract] [Full Text]  
• Murdoch, D. A. (1998). Gram-Positive Anaerobic Cocci. Clin. Microbiol. Rev. 11: 81-120 [Abstract] [Full Text]  
• Sobel, J. D. (1997). Vaginitis. NEJM 337: 1896-1903 [Full Text]  
• Hofmeyr, G J., McIntyre, J. (1997). Preventing perinatal infections. BMJ 315: 199-200 [Full Text]  
• Barfield, W. D., Wise, P. H., Rust, F. P., Rust, K. J., Gould, J. B., Gortmaker, S. L. (1996). Racial Disparities in Outcomes of Military and Civilian Births in California. Arch Pediatr Adolesc Med 150: 1062-1067 [Abstract]  
• McGregor, J. A., French, J. I., Bloom, B. S., Lee, D. W., Hauth, J. C., Hillier, S. L. (1996). Bacterial Vaginosis and Preterm Birth. NEJM 334: 1337-1339 [Full Text]  
• (1996). BACTERIAL VAGINOSIS AND PRETERM DELIVERY. JWatch General 1996: 1-1 [Full Text]  
• Hack, M., Merkatz, I. R. (1995). Preterm Delivery and Low Birth Weight -- A Dire Legacy. NEJM 333: 1772-1774 [Full Text]